Metacrine, Inc. Common Stock
MTCR
MTCR was delisted on the 8th of February, 2023.
42 hedge funds and large institutions have $105M invested in Metacrine, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.
283% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 6
62% more funds holding
Funds holding: 26 → 42 (+16)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.1% less ownership
Funds ownership: 52.37% → 51.27% (-1.1%)
24% less capital invested
Capital invested by funds: $139M → $105M (-$33.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$6.36M |
| 2 |
Millennium Management
New York
|
+$2.32M |
| 3 |
BlackRock
New York
|
+$1.83M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$712K |
| 5 |
State Street
Boston,
Massachusetts
|
+$677K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$5.96M |
| 2 |
VA
VR Adviser
New York
|
-$4.13M |
| 3 |
AG
Artal Group
Luxembourg
|
-$3.53M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.49M |
| 5 |
Goldman Sachs
New York
|
-$725K |
MTCR Hedge Fund Activity: Q4 2020 in Review
42 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q4 2020, worth a combined $105M — down 24% from $139M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MTCR positions and 6 closed out — a net gain of 17 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Franklin Resources, adding an estimated $6.36M. The largest seller was Deerfield Management, cutting an estimated $5.96M.
- 42 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q4 2020, up from 26 in Q3 2020.
- Funds reported $105M of Metacrine, Inc. Common Stock stock for Q4 2020, down 24% quarter-over-quarter.
- 23 funds opened new Metacrine, Inc. Common Stock positions in Q4 2020 and 6 closed out, a net change of +17 holders.
- The largest Metacrine, Inc. Common Stock buyer in Q4 2020 was Franklin Resources, an estimated $6.36M added.
- The largest Metacrine, Inc. Common Stock seller in Q4 2020 was Deerfield Management, an estimated $5.96M sold.
Based on aggregated 13F filings for Q4 2020.